Drugs that block calmoduLin activity inhibit cell-to-cell coupling in the epidermis of Tenebrio molitor

Insights

Antipsychotic drugs block cell-to-cell communication by inhibiting calmodulin, a calcium-dependent protein. This uncoupling effect is reversible and suggests calmodulin

Area of Science:

  • Cell Biology
  • Neuroscience
  • Pharmacology

Background:

  • Cell-to-cell communication through membrane junctions is regulated by intracellular calcium levels.
  • The role of the calcium-binding protein calmodulin in modulating junctional permeability is not fully understood.

Purpose of the Study:

  • To investigate the involvement of calmodulin in regulating cell junction permeability.
  • To determine if anticalmodulin drugs can influence cell-to-cell communication.

Main Methods:

  • Utilized standard intracellular glass microelectrode techniques to assess cell-to-cell passage of electrical current and organic tracers.
  • Tested the effects of various antipsychotic and local anesthetic drugs on junctional communication in the beetle Tenebrio molitor epidermis.
  • Examined the influence of extracellular calcium concentration and metabolic inhibitors on drug-induced uncoupling.

Main Results:

  • Several antipsychotics and local anesthetics, including chlorpromazine, blocked junctional communication and electrotonic coupling.
  • The uncoupling potency of these drugs correlated with their ability to inhibit calmodulin-dependent phosphodiesterase activity.
  • The observed uncoupling was fully reversible, and extracellular calcium levels did not affect the rate of uncoupling.

Conclusions:

  • Calmodulin plays a significant role in controlling junctional communication in the Tenebrio molitor epidermis.
  • Anticalmodulin drugs effectively block cell-to-cell communication, providing a tool to study calmodulin's function.
  • These findings suggest a mechanism by which calmodulin regulates membrane junction permeability.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Drugs Acting on Autonomic Ganglia: Blockers01:28

Drugs Acting on Autonomic Ganglia: Blockers

Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...